Drug conjugation to hyaluronan widens therapeutic indications for ovarian cancer

Management of ovarian cancer still requires improvements in therapeutic options. A drug delivery strategy was tested that allows specific targeting of tumor cells in combination with a controlled release of a cytotoxic molecule. To this aim, the efficacy of a loco-regional intraperitoneal treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Montagner, Isabella Monia, Merlo, Anna, Carpanese, Debora, Zuccolotto, Gaia, Renier, Davide, Campisi, Monica, Pasut, Gianfranco, Zanovello, Paola, Rosato, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4468323/
https://www.ncbi.nlm.nih.gov/pubmed/26097871

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4468323/
https://www.ncbi.nlm.nih.gov/pubmed/26097871

Ejemplares similares